Article
DNA Methylation-based Diagnostic and Prognostic Biomarkers for Glioblastoma
1 Jan 2020
Abstract excerpt
Glioblastomas are the most common primary central nervous system malignancy tumor in adults. Glioblastoma patients have poor prognosis, with an average survival period of approximately 14 mo after diagnosis. To date, there are a limited number of effective treatment methods for glioblastoma, and its molecular mechanisms remain elusive. In this article, we analyzed the key biomarkers and pathways in glioblastoma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
